Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Atrial Fibrillation

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Atrial Fibrillation in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, S1
Xu, W1
Dong, Z1
Zhou, M1
Lin, C1
Jin, H1
Su, Y1
Li, Q1
Wang, X1
Chang, H1
Han, W1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Atrial Fibrillation

ArticleYear
TPEN prevents rapid pacing-induced calcium overload and nitration stress in HL-1 myocytes.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:4

    Topics: Animals; Apoptosis; Atrial Fibrillation; Calcium; Cardiac Pacing, Artificial; Cell Line; Cell Surviv

2015